By combining our world-leading drug development and manufacturing expertise with flexible and adaptive customer service, our custom pharma Contract Development and Manufacturing Organisations (CDMO) solutions help innovators to overcome development hurdles. We offer complete custom services, from pre-clinical to commercialisation, providing vital pharmaceutical development, production and analysis solutions at our global network of dedicated manufacturing sites. Our team of experts and cutting-edge instrumentation enables us to deliver life-changing complex chemistry solutions for our customers.
Our tech capabilities encompass solid form sciences including crystallisation development and particle engineering. Our expertise in solid form and particle engineering enhances drug discovery and development, enabling better products and a faster route to market. Under our Pharmorphix® offering, we have a proven track record of delivering excellence for customers in early drug development. By applying our world-leading understanding of solid form science, we can improve the properties and success rates of drug candidates for the pharmaceutical industry.
Specialty capabilities include highly potent Active Pharmaceutical Ingredients (APIs) and drug linkers in addition to complex small molecule chemistry. Veranova provides an extensive portfolio of generic APIs. Our products cover a wide range of therapeutic classes, such as anti-cancer, anti-addiction, psychiatric disorders, and pain management. Our API offering is supported by our network of Good Manufacturing Practice (GMP)-compliant commercial manufacturing facilities in Europe and North America.